• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rev Med Virol . Airborne transmission of SARS-CoV-2 via aerosols

tetano

Editor, Senior Moderator
Rev Med Virol


. 2020 Oct 26;e2184.
doi: 10.1002/rmv.2184. Online ahead of print.
Airborne transmission of SARS-CoV-2 via aerosols


Laura Comber[SUP] 1 [/SUP], Eamon O Murchu[SUP] 1 [/SUP], Linda Drummond[SUP] 1 [/SUP], Paul G Carty[SUP] 1 [/SUP], Kieran A Walsh[SUP] 1 [/SUP], Cillian F De Gascun[SUP] 2 [/SUP], M?ire A Connolly[SUP] 3 [/SUP], Susan M Smith[SUP] 4 [/SUP], Michelle O'Neill[SUP] 1 [/SUP], M?ir?n Ryan[SUP] 1 5 [/SUP], Patricia Harrington[SUP] 1 [/SUP]



Affiliations

Abstract

A key consideration in the Covid-19 pandemic is the dominant modes of transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The objective of this review was to synthesise the evidence for the potential airborne transmission of SARS-CoV-2 via aerosols. Systematic literature searches were conducted in PubMed, Embase, Europe PMC and National Health Service UK evidence up to 27 July 2020. A protocol was published and Cochrane guidance for rapid review methodology was adhered to throughout. Twenty-eight studies were identified. Seven out of eight epidemiological studies suggest aerosol transmission may occur, with enclosed environments and poor ventilation noted as possible contextual factors. Ten of the 16 air sampling studies detected SARS-CoV-2 ribonucleic acid; however, only three of these studies attempted to culture the virus with one being successful in a limited number of samples. Two of four virological studies using artificially generated aerosols indicated that SARS-CoV-2 is viable in aerosols. The results of this review indicate there is inconclusive evidence regarding the viability and infectivity of SARS-CoV-2 in aerosols. Epidemiological studies suggest possible transmission, with contextual factors noted. Viral particles have been detected in air sampling studies with some evidence of clinical infectivity, and virological studies indicate these particles may represent live virus, adding further plausibility. However, there is uncertainty as to the nature and impact of aerosol transmission of SARS-CoV-2, and its relative contribution to the Covid-19 pandemic compared with other modes of transmission.

Keywords: Covid-19; SARS-CoV-2; aerosols; coronavirus; infection control; review; transmission.
 
Back
Top Bottom